Autor: Kułak, W. - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Granulocyte colony-stimulating factor potential use in the treatment of children with cerebral palsy
Autorzy:: Paszko-Patej, G.
Sienkiewicz, D.
Okurowska-Zawada, B.
Kułak, W.
Powiązania:: https://bibliotekanauki.pl/articles/1918437.pdf
Data publikacji:: 2017
Wydawca:: Uniwersytet Medyczny w Białymstoku
Tematy:: Granulocyte colony-stimulating factor
neuroprotection
studies
cerebral palsy
Opis:: Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the blood. Recent studies demonstrated the presence of CSF-receptor (G-CSFR) system in the brain and spinal cord, and their roles in neuroprotection and neural tissue repair, as well as improvement in functional recovery. G-CSF exerts neuroprotective actions through the inhibition of apoptosis and inflammation, and the stimulation of neurogenesis. This review highlights recent studies on the potential use of G-CSF in cerebral palsy.
Źródło:: Progress in Health Sciences; 2017, 7(1); 187-192
2083-1617
Pojawia się w:: Progress in Health Sciences
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Effects of granulocyte colony-stimulating factor treatment in children and patients with cerebral palsy: a preliminary report
Autorzy:: Paszko-Patej, G.
Kułak, W.
Okurowska-Zawada, B.
Sienkiewicz, D.
Wojtkowski, J.
Sochoń, K.
Kalinowska, A.
Okulczyk, K.
Topór, E.
Mirska, A.
Powiązania:: https://bibliotekanauki.pl/articles/1918403.pdf
Data publikacji:: 2017
Wydawca:: Uniwersytet Medyczny w Białymstoku
Tematy:: Granulocyte colony-stimulating factor
children
cerebral palsy
Opis:: Introduction: Recent reports have revealed that neuroinflammation and apoptosis in brains affected by cerebral palsy could be therapeutic targets. Granulocyte colony-stimulating factor (G-CSF) exerts anti-inflammatory and antiapoptosis effects and stimulates the proliferation of neural stem and progenitor cells in the brain. Purpose: To assess the efficacy and safety of G-CSF treatment in children and adolescents with CP. Materials and methods: Six patients with spastic tetraplegia CP aged 3-15 years were enrolled in this study. Five patients had GMFCS (Gross Motor Function Classification System) level at V, three children had epilepsy, and three had severe mental retardation. We used the gross motor function measure-66 (GMFM-66) to assess motor function.GCSF (5μg/kg/body/day) was administered subcutaneously for five consecutive days during the four months. The parents also evaluated the physical and mental development of their children. Results: We observed improvement in motor function in patients with CP on the GMFM-66 scale. Parents reported improvement in behavior, speech development, and a decrease in spasticity in children with CP. G-CSF therapy was well-tolerated. No side effects were observed during the study. Conclusions: Our preliminary report suggests that G-CSF treatment improves motor and mental function in patients with CP. Further studies are needed to confirm these observations
Źródło:: Progress in Health Sciences; 2017, 7(1); 78-82
2083-1617
Pojawia się w:: Progress in Health Sciences
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "Kułak, W." wg kryterium: Autor

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język